A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time
Author:
Affiliation:
1. Amyloidosis Center; Boston University School of Medicine; Boston MA USA
2. Optum; Johnston RI USA
3. Prothena Biosciences, Inc; South San Francisco CA USA
Funder
Prothena Biosciences Inc
ApotheCom
National Institutes of Health
Amyloid Research Fund
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14889/fullpdf
Reference18 articles.
1. The burden of amyloid light chain amyloidosis on health-related quality of life;Bayliss;Orphanet Journal of Rare Diseases,2017
2. Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis;Caccialanza;Annals of Hematology,2012
3. Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis;Comenzo;Leukemia,2012
4. Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival;Dispenzieri;Journal of Clinical Oncology,2001
5. The systemic amyloidoses;Falk;The New England Journal of Medicine,1997
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cardiac Amyloid Detection by PET/CT Imaging of Iodine (124I) Evuzamitide (124I-p5+14);JACC: Cardiovascular Imaging;2023-11
2. Safety and Efficacy of Propylene Glycol-Free Melphalan in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Results of a Phase II Study;Transplantation and Cellular Therapy;2023-11
3. Differences in patient‐reported outcomes (PROs) by disease severity in light chain (AL) amyloidosis;European Journal of Haematology;2023-07-03
4. Is there a representative quality‐of‐life questionnaire for patients with AL amyloidosis?—systematic literature review;British Journal of Haematology;2023-05-16
5. Health-Related Quality of Life Instruments for Clinical Trials in AL Amyloidosis: Report from the Amyloidosis Forum HRQOL Working Group;Patient Related Outcome Measures;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3